These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2873647)

  • 21. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes.
    McCarren M
    Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral treatment of type 2 diabetes mellitus].
    Olsovský J
    Vnitr Lek; 2007; 53(7-8):853-4, 856-8. PubMed ID: 17915430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral drugs for diabetes--update of current use and availability].
    Niskanen L
    Duodecim; 2004; 120(8):983-90. PubMed ID: 15185512
    [No Abstract]   [Full Text] [Related]  

  • 24. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of basal insulin in type 2 diabetes management.
    Brunton SA; White JR; Renda SM
    J Fam Pract; 2005 Oct; Suppl():S1-8. PubMed ID: 16271258
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.
    Currie CJ; Evans M; Poole CD
    Diabetes Obes Metab; 2008 Jan; 10(1):94-5. PubMed ID: 18095951
    [No Abstract]   [Full Text] [Related]  

  • 27. Counterpoint: Oral hypoglyemic agents should be used to treat diabetic pregnant women.
    Coetzee EJ
    Diabetes Care; 2007 Nov; 30(11):2980-2. PubMed ID: 17965316
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing drug usage and adverse effects. Part I: Diabetes management.
    Baron M
    Health Care Food Nutr Focus; 2005 Apr; 22(4):1, 3-7. PubMed ID: 15856659
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
    Medina Santillán R; Reyes-García G; Mateos-García E
    Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
    [No Abstract]   [Full Text] [Related]  

  • 33. Type 2 diabetes epidemic increases use of oral anti-diabetic agents.
    Capriotti T
    Medsurg Nurs; 2005 Oct; 14(5):341-7. PubMed ID: 16318117
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 35. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
    Hod M; Shafrir E
    Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feature selection and classification model construction on type 2 diabetic patients' data.
    Huang Y; McCullagh P; Black N; Harper R
    Artif Intell Med; 2007 Nov; 41(3):251-62. PubMed ID: 17707617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.